KRAS G12C inhibitor 13 Catalog No.:M24067-C CCOC(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=CC(Cl)=C1

CCOC(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=CC(Cl)=C1

KRA-533 activates WT KRAS to increase its activity in a dose-dependent manner

29)30)36-8-11(7-32-36)10-2-3-13(22)12(6-10)16(37)33-18(9-31)4-5-18/h2-3

Oral administration of an equimolar dose of ATB-337 produced > 90% less small intestinal damage and showed no significant effect on the hematocrit

KRAS G12C inhibitor 13 Catalog No.:M24067-C CCOC(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=CC(Cl)=C1KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30. Product information CAS Number: 2241719 75 3 Molecular Weight: 745. 83 Formula: C40H46F3N7O4 Chemical Name: 1 {7 [6 ethenyl 7 (5 methyl 1H indazol 4 yl) 2 {[1 (oxan 4 yl)piperidin 4 yl]oxy} 8 (2,2,2 trifluoroethoxy)quinazolin 4 yl] 2,7 diazaspiro[3. 5]nonan 2 yl}prop 2 en 1 one Smiles: